Topics:
Head and Neck Cancers • Radiation Oncology
In what situation, if any, would you combine immunotherapy concurrently with radiation for patients with head and neck cancer?
What about in the metastatic and non-metastatic setting, specifically? Any additional treatment (dose/fractionation) or toxicity considerations for this combination?
Answer from: Radiation Oncologist at Academic Institution
In the definitive setting I would only use this combination in the setting of a clinical trial. In the recurrent/metastatic setting would consider for patients in need of palliation or with progression in a limited number of sites (with good responses elsewhere). I would prefer this be done on proto...
Sign in or Register to read more